Anesthetic Considerations for Second-Trimester Surgical Abortions
- PMID: 36729414
- DOI: 10.1213/ANE.0000000000006321
Anesthetic Considerations for Second-Trimester Surgical Abortions
Abstract
Although most abortion care takes place in the office setting, anesthesiologists are often asked to provide anesthesia for the 1% of abortions that take place later, in the second trimester. Changes in federal and state regulations surrounding abortion services may result in an increase in second-trimester abortions due to barriers to accessing care. The need for interstate travel will reduce access and delay care for everyone, given limited appointment capacity in states that continue to support bodily autonomy. Therefore, anesthesiologists may be increasingly involved in care for these patients. There are multiple, unique anesthetic considerations to provide safe and compassionate care to patients undergoing second-trimester abortion. First, a multiday cervical preparation involving cervical osmotic dilators and pharmacologic agents results in a time-sensitive, nonelective procedure, which should not be delayed or canceled due to risk of fetal expulsion in the preoperative area. In addition, a growing body of literature suggests that the older anesthesia dogma that all pregnant patients require rapid-sequence induction and an endotracheal tube can be abandoned, and that deep sedation without intubation is safe and often preferable for this patient population through 24 weeks of gestation. Finally, concomitant substance use disorders, preoperative pain from cervical preparation, and intraoperative management of uterine atony in a uterus that does not yet have mature oxytocin receptors require additional consideration.
Copyright © 2023 International Anesthesia Research Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester.Am J Obstet Gynecol. 1993 Feb;168(2):633-7. doi: 10.1016/0002-9378(93)90509-h. Am J Obstet Gynecol. 1993. PMID: 8438943
-
Intrauterine administration of drugs for termination of pregnancy in the second trimester.Baillieres Clin Obstet Gynaecol. 1990 Jun;4(2):327-49. doi: 10.1016/s0950-3552(05)80230-5. Baillieres Clin Obstet Gynaecol. 1990. PMID: 2225603 Review.
-
D & E midtrimester abortion: a medical innovation.Women Health. 1982 Spring;7(1):49-55. doi: 10.1300/J013v07n01_06. Women Health. 1982. PMID: 7180000
-
Update on second-trimester surgical abortion.Curr Opin Obstet Gynecol. 2016 Dec;28(6):510-516. doi: 10.1097/GCO.0000000000000318. Curr Opin Obstet Gynecol. 2016. PMID: 27684047 Review.
-
The safety of deep sedation without intubation for abortion in the outpatient setting.J Clin Anesth. 2011 Sep;23(6):437-42. doi: 10.1016/j.jclinane.2011.05.001. Epub 2011 Aug 9. J Clin Anesth. 2011. PMID: 21831622
References
-
- Jones RK, Jerman J. Population group abortion rates and lifetime incidence of abortion: United States, 2008–2014. Am J Public Health. 2017;107:1904–1909.
-
- Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374:843–852.
-
- Kortsmit K, Mandel MG, Reeves JA, et al. Abortion surveillance—United States, 2019. MMWR Surveill Summ. 2021;70:1–29.
-
- Jones RK, Finer LB. Who has second-trimester abortions in the United States? Contraception. 2012;85:544–551.
-
- Turok DK, Gurtcheff SE, Esplin MS, et al. Second trimester termination of pregnancy: a review by site and procedure type. Contraception. 2008;77:155–161.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical